PsyKey Inc. Adds Mental Health Support Advocate Dr. Shahiem Hartley to Its Medical Advisory Board

PsyKey Inc. Adds Mental Health Support Advocate Dr. Shahiem Hartley to Its Medical Advisory Board

CARSON CITY, NV, Dec. 06 2022 (GLOBE NEWSWIRE) — CECOS, INC. (OTC PINK: CEOS) (“CeCors” or the “Company”), through its wholly owned subsidiary PsyKey Inc., an innovative wellness company, is pleased to announce the addition of Dr. Shahiem Hartley, a published medical and corporate wellness professional, to its Medical Advisory Board.

Dr. Hartley completed an MD, Masters and Pharmacy degree in South Africa before moving to Edmonton, Alberta where he currently practices family medicine. During the pandemic, Dr. Hartley has pivoted her business to helping patients with coping strategies, stress, and mental health management. Dr. Hartley then leveraged these strategies to develop a corporate mental wellness consulting firm. Dr. Hartley offers one-on-one and large-scale seminars and training sessions on mental improvement and wellness.

“As a company focused on overall optimal wellness, it made perfect sense to bring in a professional with such passion and understanding for mental health, stress management, and a desire to educate. So As we get closer to realizing opportunities in the mental wellness space, we are happy to welcome such a charismatic and compassionate personality to our growing team,” said Amar Bhatal.

“Covid has really underscored how important mental health and wellbeing is to human survival. There were so many people suffering from anxiety, depression, overwhelming emotions and a plethora of other issues mental health. I have always believed that awareness and education are the first steps to becoming the improved versions of ourselves and leading to a happier and better life. PsyKey’s motto “optimizing your routine” goes from hand in hand with what I would like to accomplish as a physician and mental health educator. I am very excited to work with PsyKey to create and launch an education and awareness platform.” concluded Dr. Hartley.

Shareholders and interested parties are invited to follow @PSYKEY on Twitter for all company updates.

About PsyKey Inc.

PsyKey Inc. is a wholly owned subsidiary of CeCors, Inc. PsyKey is an innovative wellness company specializing in the development and commercialization of mycology-based entheogenic, adaptogenic and nootropic ingredients and formulations. From functional to psychedelic, PsyKey believes in the magic of mushrooms. As part of our optimal wellness strategy, PsyKey understands the importance of access to support services and healthcare professionals, and is committed to developing tools that will help break down barriers and ensure inclusiveness.

For more information:
Publicly listed company (OTC PINK: CEOS)
Website: www.psykeyworld.com
E-mail: info@psykeyworld.com
Follow us on twitter: https://twitter.com/PsyKeyworld

Forward-looking statements:

Safe Harbor Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995 The forward-looking statements contained in this press release include the intention, belief or expectations of the company and the members of its management team concerning the future business operations of the company and the assumptions on which these statements are based. Potential investors are cautioned that these forward-looking statements are not guarantees of future performance, involve risks and uncertainties, and that actual results may differ materially from those contemplated by these forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to achieve anticipated sales during negotiation, lack of revenue growth, customer dropouts, failure to achieve improvements performance, efficiency and profitability, and adverse developments in litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock . Other factors that could cause actual results to differ materially from those contemplated in this press release can also be found on the Company’s website. The Company assumes no responsibility for updating forward-looking statements.


#PsyKey #Adds #Mental #Health #Support #Advocate #Shahiem #Hartley #Medical #Advisory #Board

Leave a Comment

Your email address will not be published. Required fields are marked *